Compare SNPS & HCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SNPS | HCA |
|---|---|---|
| Founded | 1986 | 1968 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | EDP Services | Hospital/Nursing Management |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 90.9B | 93.7B |
| IPO Year | 1994 | 2009 |
| Metric | SNPS | HCA |
|---|---|---|
| Price | $453.94 | $498.76 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 25 | 26 |
| Target Price | ★ $589.55 | $480.00 |
| AVG Volume (30 Days) | ★ 1.8M | 1.4M |
| Earning Date | 12-08-2026 | 10-27-2026 |
| Dividend Yield | N/A | ★ 0.62% |
| EPS Growth | N/A | ★ 28.77 |
| EPS | 3.27 | ★ 22.05 |
| Revenue | $5,081,542,000.00 | ★ $75,600,000,000.00 |
| Revenue This Year | $37.81 | $4.71 |
| Revenue Next Year | $13.18 | $3.16 |
| P/E Ratio | $141.26 | ★ $22.73 |
| Revenue Growth | ★ 20.87 | 7.08 |
| 52 Week Low | $362.55 | $353.99 |
| 52 Week High | $539.48 | $556.52 |
| Indicator | SNPS | HCA |
|---|---|---|
| Relative Strength Index (RSI) | 48.19 | 61.30 |
| Support Level | $440.66 | $420.98 |
| Resistance Level | $472.39 | $516.81 |
| Average True Range (ATR) | 16.93 | 15.97 |
| MACD | -1.75 | 0.99 |
| Stochastic Oscillator | 31.55 | 72.30 |
Synopsys is a provider of electronic design automation software and intellectual property products. EDA software automates and aids in the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Synopsys' comprehensive portfolio is benefiting from a convergence of semiconductor companies moving up the stack of technologies toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers alongside secular digitalization of various end markets benefits EDA vendors like Synopsys.
HCA Healthcare is a Nashville-based healthcare provider organization operating the largest collection of acute-care hospitals in the United States. As of December 2025, the firm owned and operated 190 hospitals and over 2,500 outpatient facillities across 19 states and a small foothold in the United Kingdom.